Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Levo Gen 2 Tinnitus Therapy System

K-Number: K260413 · 2026-08-13

Decision Date2026-08-13
Product CodeKLW
Advisory CommitteeEN
DecisionSubstantially Equivalent

Device Summary

Levo Gen 2 Tinnitus Therapy System is the device name listed in this FDA 510(k) record. The listed applicant is Levo Medical Corporation. It received FDA 510(k) clearance on 2026-08-13 under 510(k) number K260413. The device is classified under product code KLW. It was reviewed by the EN advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Levo Gen 2 Tinnitus Therapy System?

Levo Gen 2 Tinnitus Therapy System is a medical device that received FDA 510(k) clearance on 2026-08-13. The listed applicant is Levo Medical Corporation. The 510(k) number is K260413.

When did Levo Gen 2 Tinnitus Therapy System receive FDA 510(k) clearance?

Levo Gen 2 Tinnitus Therapy System received FDA 510(k) clearance on 2026-08-13, under 510(k) number K260413.

Who is the listed applicant for Levo Gen 2 Tinnitus Therapy System?

The FDA 510(k) record lists Levo Medical Corporation as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Levo Gen 2 Tinnitus Therapy System?

The FDA product code for Levo Gen 2 Tinnitus Therapy System is KLW.

Related Devices (Code: KLW)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.